Physician profile
Dan E Miulli
NPI 1700993573
$14,137.34
in general payments reported to CMS, 2019-2025
10 companies · $318 in 2025
The $318 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $24.68 · 2021: $129 · 2022: $130 · 2023: $119 · 2024: $328 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $12,895.62 | 2019 | |
| Medtronic, INC. | $634.02 | 2021-2025 | Mazor X System, Cd Horizon Spinal System, Infinity Occipitocervical Upper Thoracic System |
| Medtronic USA, INC. | $217.22 | 2019-2020 | |
| Axogen | $144.78 | 2025 | |
| Integra Lifesciences Corporation | $110.41 | 2021-2022 | |
| Bioventus LLC | $35.02 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Astrazeneca Pharmaceuticals LP | $32.90 | 2021-2024 | Andexxa |
| Microtransponder, INC. | $26.56 | 2023 | |
| Nevro Corp. | $24.27 | 2024 | Senza |
| Orthofix Medical, INC. | $16.54 | 2025 | Spinal-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Miulli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.